Advanced Merkel Cell Carcinoma

3 clinical trials · Condition

Record	Firm	Date
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies (NCT04902040)	M.D. Anderson Cancer Center	2021-04-14

Every clearance here is in the API, with alerts when new ones post.